Cancer Drug Website Draws FDA's Ire For Promoting A Product In Clinical Trials
This article was originally published in The Pink Sheet Daily
Executive Summary
Keryx Biopharmaceuticals is cited for claiming on its website that its investigational oncology drug perifosine is safe and effective.